TCOYD

TCOYD Guided by the belief that every person with diabetes has the right to live a healthy, happy, and pro

Guided by the belief that every person with diabetes has the right to live a healthy, happy, and productive life, Taking Control of Your Diabetes educates and motivates people with diabetes to take a more active role in their condition.

*We love sharing the latest and greatest in diabetes education, but we are not your doctors! All of the information on our website, in our videos, on our podcasts

, on our social media platforms, and in any other current or future communication method is for the purposes of general education only. Always consult with your medical team for testing, diagnosis, treatment, and medical advice before making any changes to your healthcare. AND if you think you are having a medical emergency, call 911.*

05/31/2026

When choosing a CGM what matters most to you?

In this episode, Dr. E, Dr. P, and diabetes nurse practitioner and founder of The Diabetes Collective, Rachael Sood, talk about why choosing the right sensor often comes down to personal preference and lifestyle.

Some people prioritize compatibility with their pump, while others care more about comfort, wear time, size, or simply sticking with a sensor they already trust. That’s part of the conversation around the Dexcom G7 15-day sensor, which offers a longer wear option, slightly smaller size, and improved adhesive for people looking for fewer sensor changes and added convenience.

The discussion is a reminder that diabetes devices and technology work best when people have flexibility and choices that fit their individual needs and routines.

Would longer sensor wear time make a difference for you?

👉 Watch the full episode through here: https://bit.ly/4tTh2Rj

Produced with support from Dexcom

05/30/2026

What’s next for diabetes devices and technology—and could they become easier to live with every day?

In this episode, Dr. P, Dr. E, and diabetes nurse practitioner and founder of The Diabetes Collective, Rachael Sood, talk about some of the newest updates coming to diabetes technology, including the upcoming MiniMed Flex pump.

The conversation touches on how pump design, size, and usability matter more than people may realize. As diabetes devices and technology continue to improve, many companies are focusing not just on glucose management, but also on making devices feel more practical and comfortable to wear every day.

It’s a helpful look at how diabetes technology continues to evolve to better fit into our lives.

What’s one thing you would change about current diabetes devices?

👉 Watch the full episode through here: https://bit.ly/4tTh2Rj

Produced with support from Minimed

05/29/2026

Afrezza, an inhaled ultra rapid-acting insulin, is now FDA approved for children, adolescents, and teens ages 6–17. It works quickly and clears quickly, helping with after-meal blood sugar spikes while reducing delayed lows.

Unlike traditional rapid-acting insulin, Afrezza can be taken at the start of a meal—or even after eating—and may also be useful for snacks and correction doses when timing doesn’t always go as planned.

This approval was based on the INHALE-1 study, which evaluated Afrezza in children and teens. One of the biggest questions parents have is safety, especially around the lungs. In the study, children completed lung function tests (FEV1) and were followed closely for a year, with findings consistent with what has been seen in adults over the past 12 years, showing no new safety concerns. Afrezza is not recommended for those with underlying lung conditions like asthma, and screening is part of the process before starting.

We’ll also be sharing the experience of a teen from the INHALE-1 study who switched from multiple daily injections to Afrezza and chose to continue using it because it fit better into his active lifestyle. Both parents and kids in the study reported high satisfaction with the flexibility, convenience, and reduced burden around mealtime insulin.

This approval gives families another option to consider as they think about what works best for their diabetes care. We’ll be sharing more videos with pediatric endocrinologist Dr. Anna Cymbaluk, along with patient and parent experiences, to help answer common questions.

What questions do you have about inhaled insulin for kids?

👉 Stay tuned for more videos and content to learn more!

Supported by an unrestricted educational grant from Mannkind Corporation

There’s a brand new insulin option now available for kids living with type 1 diabetes.Afrezza, an inhaled ultra rapid-ac...
05/29/2026

There’s a brand new insulin option now available for kids living with type 1 diabetes.

Afrezza, an inhaled ultra rapid-acting insulin, is now FDA approved for children, adolescents and teens ages 6-17. It works quickly and clears quickly, helping with after-meal blood sugar spikes and reducing delayed lows.

Unlike traditional rapid-acting insulin, Afrezza can be taken at the start of a meal—or even after eating—and may also be useful for snacks and correction doses when timing doesn’t always go as planned.

This approval was based on the INHALE-1 study, which evaluated Afrezza in children and teens. One of the main questions parents have is safety, especially around the lungs. In the study, children completed lung function tests (FEV1) and were followed closely for a year, with findings consistent with what has been seen in adults over the past 12 years in that there are no safety concerns. Afrezza is not recommended for those with underlying lung conditions like asthma, and screening is part of the process before starting.

We’ll also be sharing the experience of a teen from the INHALE-1 study who switched from multiple daily injections to Afrezza and chose to continue using it because it fit better into his active routine. Both parents and kids in the study shared high satisfaction with the flexibility, convenience, and reduced burden around mealtime insulin.

This approval gives families another option to learn about as they think through what works best for their diabetes care. We’ll be sharing more videos with pediatric endocrinologist Dr. Anna Cymbaluk, along with patient and parent experiences, to help answer common questions.

What questions do you have about inhaled insulin for kids?

👉 Stay tuned for more videos and content to learn more!

Have you ever noticed your blood sugar spike after a meal—then drop a few hours later?Reactive hypoglycemia can happen w...
05/28/2026

Have you ever noticed your blood sugar spike after a meal—then drop a few hours later?

Reactive hypoglycemia can happen when blood sugar rises quickly after eating, leading the body to release more insulin than needed, causing a drop shortly after. It’s often seen in people with prediabetes and can be an early sign that glucose regulation is starting to change.

The good news is that small adjustments can help. Paying attention to how different foods affect you, focusing on balanced meals, and spacing out meals throughout the day can make a difference in keeping things more stable.

It’s also a helpful reminder that your body is giving you feedback—and tools like a CGM can help you better understand what’s happening.

What foods tend to cause these kinds of swings for you? Share your thoughts below!

Read the full article to learn more here: https://bit.ly/49cpcwO

05/27/2026

How do you choose the right diabetes devices and technology that suits your lifestyle?

In this episode, Dr. E, Dr. P, and diabetes nurse practitioner and founder of The Diabetes Collective, Rachael Sood, talk about why choosing a pump or CGM is about more than just features and numbers.

For some people, it’s about exercise and staying active. For others, it’s comfort, appearance, work, sleep, travel, or wanting something that feels easier to manage day to day. The conversation highlights how diabetes devices and technology should support your life—not force you to adjust everything around it.

There’s no single “best” device for everyone. The best technology is the one that fits your needs, preferences, and routine.

What matters most to you when choosing diabetes devices and technology?

👉 Watch the full episode through here:https://bit.ly/4tTh2Rj

05/26/2026

What diabetes devices and technology are actually making a difference right now?

In this episode, Dr. E and Dr. P are joined by diabetes nurse practitioner and founder of The Diabetes Collective, Rachael Sood, to talk through the latest updates in diabetes technology and how these devices might fit your lifestyle.

The conversation covers insulin pumps, CGMs, automated insulin delivery systems, continuous ketone monitoring, and where diabetes technology may be headed over the next few years. They also talk honestly about the challenges that still exist and what people living with diabetes are really looking for from these systems.

It’s a practical and encouraging conversation about how diabetes devices and technology continue to evolve and why having more options matters.

What diabetes technology update are you most interested in right now?

👉 Watch the full episode through here: https://bit.ly/4tTh2Rj

05/23/2026

What can you do if you’re told you have fatty liver?

In this episode, Dr. Julio Gutierrez explains that care often begins with everyday habits like physical activity and weight management, along with additional treatment options when needed.

He shares how these approaches can work together to support liver health and help the body move in a better direction over time. It’s about building a plan that fits your situation and sticking with it.

There are more options available today, and that can make a difference.

What’s one step you’ve taken to support your health?

👉 Watch the full episode through here: https://bit.ly/3Rnmmib

Produced with support from Madrigal

As we head into the week of science at the beginning of June in New Orleans, we are excited to share an event we're co-h...
05/20/2026

As we head into the week of science at the beginning of June in New Orleans, we are excited to share an event we're co-hosting with Kriya Therapeutics during ADA 2026.

Gene Therapy. Redefined: Taking Control of What's Next in T1D is an evening reception bringing together researchers, clinicians, and members of the T1D community to talk through one of the most exciting frontiers in diabetes research today: AAV (adeno-associated virus) gene therapy.

Kriya is developing a potentially "one-and-done" treatment designed to improve glycemic control by improving the retention of glucose in muscles. It's a novel direction in T1D, and the team building it will be in the room to talk about where the science stands, what's on deck, and what it could mean for our community in the years ahead.

Join Dr. Steven Edelman, Dr. Jeremy Pettus, and Dr. Shankar Ramaswamy (Co-Founder and CEO of Kriya Therapeutics) for an evening of science, conversation, and community.

Saturday, June 6, 2026 5:30 – 8:00 PM CT (brief comments around 6:00 PM) Rosie's On The Roof, Higgins Hotel 1000 Magazine St, New Orleans, LA

Open-house format — drop in anytime, mingle with the hosts and Kriya's leadership team.

RSVP at the link in our bio. We'd love to see you there.

We'd love to see you there! RSVP here: https://bit.ly/3PpcX9r

What if your diabetes diagnosis doesn’t quite fit the usual type 1 or type 2 picture?In this article, we take a closer l...
05/20/2026

What if your diabetes diagnosis doesn’t quite fit the usual type 1 or type 2 picture?

In this article, we take a closer look at latent autoimmune diabetes in adults (LADA)—a slower-moving form of autoimmune diabetes that is often mistaken for type 2. Those who have been diagnosed with LADA may still be making some insulin at first, which is why it can appear like type 2 early on, but over time insulin production continues to decline as the immune system targets the beta cells.

Because of this, many are initially treated with oral medications, but may notice that blood sugar becomes harder to manage as time goes on.

That’s where understanding the underlying cause becomes important. Identifying LADA earlier can help guide treatment decisions, including when insulin may be needed, and help avoid delays in getting the right care.

It’s a helpful reminder that diabetes can look different from person to person—and sometimes it’s worth asking a few more questions.

Have you or a loved one ever been misdiagnosed? Share your thoughts in below!

👉 Read the full article through here: https://bit.ly/42oJvDt

Address

San Diego, CA
92121

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Telephone

+18009982693

Website

Alerts

Be the first to know and let us send you an email when TCOYD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category